Results 41 to 50 of about 544,105 (249)

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

Hypnotisme et suggestion, Discussion

open access: yes, 1890
HYPNOTISME ET SUGGESTION, DISCUSSION Congrès international de psychologie physiologique (-) Hypnotisme et suggestion, Discussion (-
Ochrovicz
core   +3 more sources

A content analysis on the outlook of consumers towards coffee shops

open access: yesJournal of Hospitality, Tourism & Cultural Research
This research study explores customers' underlying standards of business strategy within the context of coffee shops. It investigates leveraging customer feedback to improve the products, services, and overall customer experience. Specifically, the paper
Allysa M. Medrano   +4 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Hypnotismus und Suggestion

open access: yes, 1892
HYPNOTISMUS UND SUGGESTION Hypnotismus und Suggestion (-
Wundt, Wilhelm
core   +2 more sources

THE ENERGY OF POETIC WORDS: MYTH OR REALITY?

open access: yesPolylinguality and Transcultural Practices, 2015
The article is aimed at showing that the poetic words may have a special energy, a special mystical power.
Valentina A Maslova
doaj  

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

The Potential of Web-Based Suggestion Schemes in a University Setting [PDF]

open access: yes, 2002
Suggestion schemes have a long history in both public and private sectors, yet they have never become established in British universities. This paper discuesses the benefits that could accrue to higher education institutions (HEIs) from the adoption of ...
Helbling, Cornelia   +2 more
core  

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy